Talvey 3 mg/1.5 ml

Talvey 3 mg/1.5 ml is a medicine authorised by Swissmedic under authorisation number 69049. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 October 2023 and the authorisation is limited until 31 December 2026. ATC code L01FX29 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69049
  • ATC L01FX29
  • Biotechnological medicines
Authorisation data
Authorisation number69049
NameTalvey 3 mg/1.5 ml
Full nameTalvey 3 mg/1.5 ml, Injektionslösung
Authorisation holderJanssen-Cilag AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FX29
First authorisation30 October 2023
Authorisation validity31 December 2026
Strengths
No.NameDispensing categoryAuthorisation date
1Talvey 3 mg/1.5 ml, InjektionslösungA30 October 2023
2Talvey 40 mg/1.0 ml, InjektionslösungA30 October 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FX2907.16.1.A
21Durchstechflasche(n)L01FX2907.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Talvey 3 mg/1.5 ml authorised in Switzerland?

Yes. Talvey 3 mg/1.5 ml is authorised by Swissmedic under authorisation number 69049, data as of 01 September 2026. The authorisation is limited until 31 December 2026.

Which dispensing category does Talvey 3 mg/1.5 ml have?

Talvey 3 mg/1.5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Talvey 3 mg/1.5 ml?

The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com